| 4.30 | +0.10 / +2.38% |
Data as of 3:59pm ET | Day’s Change |
| 4.30 | |
Volume: 10.6K |
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +39.53% increase from the last price of 4.30.

The current consensus among 4 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since June, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




